Recently at a conference held by the Institute of Medicine (IOM), low participation in new clinical trials and research were discussed between industry professionals. One viewpoint states mistrust of clinical trials, science in general and the motives of the industry are hindering recruitment. Gaining the public’s trust and providing results could be the key to increasing participation. To read more, go here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.
5 Common Errors in the Informed Consent Process
Pearl IRB 2024 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests